301 related articles for article (PubMed ID: 16039540)
41. Assessment of global and local region-based bilateral mammographic feature asymmetry to predict short-term breast cancer risk.
Li Y; Fan M; Cheng H; Zhang P; Zheng B; Li L
Phys Med Biol; 2018 Jan; 63(2):025004. PubMed ID: 29226849
[TBL] [Abstract][Full Text] [Related]
42. Mammographic parenchymal patterns as risk indicators for incident cancer in a screening program: an extended analysis.
Krook PM
AJR Am J Roentgenol; 1978 Dec; 131(6):1031-5. PubMed ID: 104567
[TBL] [Abstract][Full Text] [Related]
43. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
[TBL] [Abstract][Full Text] [Related]
44. Symmetry of projection in the quantitative analysis of mammographic images.
Byng JW; Boyd NF; Little L; Lockwood G; Fishell E; Jong RA; Yaffe MJ
Eur J Cancer Prev; 1996 Oct; 5(5):319-27. PubMed ID: 8972250
[TBL] [Abstract][Full Text] [Related]
45. Automated analysis of mammographic densities.
Byng JW; Boyd NF; Fishell E; Jong RA; Yaffe MJ
Phys Med Biol; 1996 May; 41(5):909-23. PubMed ID: 8735257
[TBL] [Abstract][Full Text] [Related]
46. Breast MRI texture analysis for prediction of BRCA-associated genetic risk.
Vasileiou G; Costa MJ; Long C; Wetzler IR; Hoyer J; Kraus C; Popp B; Emons J; Wunderle M; Wenkel E; Uder M; Beckmann MW; Jud SM; Fasching PA; Cavallaro A; Reis A; Hammon M
BMC Med Imaging; 2020 Jul; 20(1):86. PubMed ID: 32727387
[TBL] [Abstract][Full Text] [Related]
47. Screening mammography and risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study.
Narod SA; Lubinski J; Ghadirian P; Lynch HT; Moller P; Foulkes WD; Rosen B; Kim-Sing C; Isaacs C; Domchek S; Sun P;
Lancet Oncol; 2006 May; 7(5):402-6. PubMed ID: 16648044
[TBL] [Abstract][Full Text] [Related]
48. Breast cancer risk and measured mammographic density.
Yaffe MJ; Boyd NF; Byng JW; Jong RA; Fishell E; Lockwood GA; Little LE; Tritchler DL
Eur J Cancer Prev; 1998 Feb; 7 Suppl 1():S47-55. PubMed ID: 10866036
[TBL] [Abstract][Full Text] [Related]
49. A novel method of determining breast cancer risk using parenchymal textural analysis of mammography images on an Asian cohort.
Tan M; Mariapun S; Yip CH; Ng KH; Teo SH
Phys Med Biol; 2019 Jan; 64(3):035016. PubMed ID: 30577031
[TBL] [Abstract][Full Text] [Related]
50. Impact of Age at Primary Breast Cancer on Contralateral Breast Cancer Risk in BRCA1/2 Mutation Carriers.
van den Broek AJ; van 't Veer LJ; Hooning MJ; Cornelissen S; Broeks A; Rutgers EJ; Smit VT; Cornelisse CJ; van Beek M; Janssen-Heijnen ML; Seynaeve C; Westenend PJ; Jobsen JJ; Siesling S; Tollenaar RA; van Leeuwen FE; Schmidt MK
J Clin Oncol; 2016 Feb; 34(5):409-18. PubMed ID: 26700119
[TBL] [Abstract][Full Text] [Related]
51. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Graeser MK; Engel C; Rhiem K; Gadzicki D; Bick U; Kast K; Froster UG; Schlehe B; Bechtold A; Arnold N; Preisler-Adams S; Nestle-Kraemling C; Zaino M; Loeffler M; Kiechle M; Meindl A; Varga D; Schmutzler RK
J Clin Oncol; 2009 Dec; 27(35):5887-92. PubMed ID: 19858402
[TBL] [Abstract][Full Text] [Related]
52. Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age.
van der Kolk DM; de Bock GH; Leegte BK; Schaapveld M; Mourits MJ; de Vries J; van der Hout AH; Oosterwijk JC
Breast Cancer Res Treat; 2010 Dec; 124(3):643-51. PubMed ID: 20204502
[TBL] [Abstract][Full Text] [Related]
53. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
[TBL] [Abstract][Full Text] [Related]
54. Field cancerization in the understanding of parenchymal analysis of mammograms for breast cancer risk assessment.
Miranda DA; Pertuz S
Med Hypotheses; 2020 Mar; 136():109511. PubMed ID: 31837523
[TBL] [Abstract][Full Text] [Related]
55. Phenocopy breast cancer rates in Israeli BRCA1 BRCA2 mutation carrier families: is the risk increased in non-carriers?
Bernholtz S; Laitman Y; Kaufman B; Shimon-Paluch S; Friedman E
Breast Cancer Res Treat; 2012 Apr; 132(2):669-73. PubMed ID: 22113258
[TBL] [Abstract][Full Text] [Related]
56. Mammographic pattern analysis: an emerging risk assessment tool.
Karellas A
Acad Radiol; 2007 May; 14(5):511-2. PubMed ID: 17434063
[No Abstract] [Full Text] [Related]
57. Deep learning in breast cancer risk assessment: evaluation of convolutional neural networks on a clinical dataset of full-field digital mammograms.
Li H; Giger ML; Huynh BQ; Antropova NO
J Med Imaging (Bellingham); 2017 Oct; 4(4):041304. PubMed ID: 28924576
[TBL] [Abstract][Full Text] [Related]
58. Detection of breast masses in mammograms by density slicing and texture flow-field analysis.
Mudigonda NR; Rangayyan RM; Desautels JE
IEEE Trans Med Imaging; 2001 Dec; 20(12):1215-27. PubMed ID: 11811822
[TBL] [Abstract][Full Text] [Related]
59. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
[TBL] [Abstract][Full Text] [Related]
60. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study.
Boyd NF; Byng JW; Jong RA; Fishell EK; Little LE; Miller AB; Lockwood GA; Tritchler DL; Yaffe MJ
J Natl Cancer Inst; 1995 May; 87(9):670-5. PubMed ID: 7752271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
